|
USP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.576900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.248400E-02 |
| Normal-vs-Stage2 |
2.741600E-01 |
| Normal-vs-Stage3 |
2.234800E-04 |
| Normal-vs-Stage4 |
2.11319999999793E-05 |
| Stage1-vs-Stage2 |
9.249600E-01 |
| Stage1-vs-Stage3 |
1.147780E-02 |
| Stage1-vs-Stage4 |
1.920680E-03 |
| Stage2-vs-Stage3 |
8.299600E-02 |
| Stage2-vs-Stage4 |
2.035900E-02 |
| Stage3-vs-Stage4 |
4.694600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.223770E-03 |
| Normal-vs-AfricanAmerican |
6.659200E-03 |
| Normal-vs-Asian |
9.240400E-01 |
| Caucasian-vs-AfricanAmerican |
4.918800E-01 |
| Caucasian-vs-Asian |
4.297800E-01 |
| AfricanAmerican-vs-Asian |
2.777200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.958800E-04 |
| Normal-vs-Female |
1.993800E-02 |
| Male-vs-Female |
3.417000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.858400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.679820E-03 |
| Normal-vs-Age(61-80Yrs) |
1.051840E-02 |
| Normal-vs-Age(81-100Yrs) |
6.581100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.982200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.410400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.675400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.491200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.410800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.414000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.310800E-01 |
| Normal-vs-Grade 2 |
8.509700E-02 |
| Normal-vs-Grade 3 |
1.790520E-04 |
| Normal-vs-Grade 4 |
8.35419999956066E-07 |
| Grade 1-vs-Grade 2 |
2.990200E-01 |
| Grade 1-vs-Grade 3 |
4.318400E-02 |
| Grade 1-vs-Grade 4 |
6.237800E-03 |
| Grade 2-vs-Grade 3 |
2.182200E-02 |
| Grade 2-vs-Grade 4 |
2.610200E-04 |
| Grade 3-vs-Grade 4 |
2.095800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.014030E-01 |
| Normal-vs-ccB subtype |
4.061500E-02 |
| ccA subtype-vs-ccB subtype |
4.838800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.827870E-02 |
| Normal-vs-N1 |
9.522200E-01 |
| N0-vs-N1 |
6.829000E-01 |
|
|
